APA aipamena

Fotaki, G., Jin, C., Kerzeli, I. K., Ramachandran, M., Martikainen, M., Karlsson-Parra, A., . . . Essand, M. (2017). Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models. Oncoimmunology.

Chicago Style aipamena

Fotaki, Grammatiki, Chuan Jin, Iliana Kyriaki Kerzeli, Mohanraj Ramachandran, Minttu-Maria Martikainen, Alex Karlsson-Parra, Di Yu, and Magnus Essand. "Cancer Vaccine Based On a Combination of an Infection-enhanced Adenoviral Vector and Pro-inflammatory Allogeneic DCs Leads to Sustained Antigen-specific Immune Responses in Three Melanoma Models." Oncoimmunology 2017.

MLA aipamena

Fotaki, Grammatiki, et al. "Cancer Vaccine Based On a Combination of an Infection-enhanced Adenoviral Vector and Pro-inflammatory Allogeneic DCs Leads to Sustained Antigen-specific Immune Responses in Three Melanoma Models." Oncoimmunology 2017.